Jonathan

Biography

He with over 25 years’ experience in mergers and acquisitions, fundraisings and business process design. Prior to joining Integumen in 2016, Chris was Chief Financial Officer of Greenstar, one of Ireland’s largest recycling and waste-to-energy companies, with a turnover of €98 million and employing 675 staff. Previously, Chris held a number of senior finance positions in manufacturing, design and engineering companies within a range of private equity, PLC and owner-manager environments. He is a Fellow of Chartered Accountants Ireland, having qualified with Pannell Kerr Forster in 1989. He with over 25 years’ experience in mergers and acquisitions, fundraisings and business process design. Prior to joining Integumen in 2016, Chris was Chief Financial Officer of Greenstar, one of Ireland’s largest recycling and waste-to-energy companies, with a turnover of €98 million and employing 675 staff. Previously, Chris held a number of senior finance positions in manufacturing, design and engineering companies within a range of private equity, PLC and owner-manager environments. He is a Fellow of Chartered Accountants Ireland, having qualified with Pannell Kerr Forster in 1989.

Research Interest

Venn Life Sciences is an Integrated Drug Development Partner offering a unique combination of drug development expertise and clinical trial design and management. This enables us to create, plan and execute drug and medical device development programs effectively and seamlessly for our clients. We have dedicated operations in Ireland, France, Germany, the Netherlands, the UK, the US, and European-wide representation